FGFR4-IN-19

Overview

FGFR4-IN-19 (compound 8B) is a potent covalent fibroblast growth factor receptor 4 ( FGFR4 ) inhibitor ( IC 50 =1.2 nM). FGFR4-IN-19 achieves high efficiency and isotype selectivity by covalently targeting a rare cysteine (C552) in the FGFR4 kinase domain. FGFR4-IN-19 can be used for hepatocellular carcinoma (HCC) research.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > FGFR

Product Information

• Catalog No.: HY-158248
• CAS No.: 3036751-84-2
• Molecular Formula: C21H14Cl3N5O4
• Molecular Weight: 506.73
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source